Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Biotech Slides into Boston’s Fenway Neighborhood
Decibel Therapeutics relocated its headquarters and lab space into Samuels & Associates’ Van Ness mixed-use development in Boston’s Fenway neighborhood. The biotech company took 32,000 square feet at 1325 Boylston St., which signals a broader shift in The Fenway’s transformation.
Decibel, which is developing hearing loss treatments, is the first biotech company to move into the area, joining a burgeoning health and technology hub.
Samuels & Associates’ Peter Sougarides says, “Decibel’s headquarters and lab really mark a tipping point for health innovation companies falling in love with The Fenway.”
Van Ness, which opened in summer 2015, consists of a 172-unit residential tower and a 237,000-square-foot office tower atop a 165,000-square-foot retail base.
Decibel Therapeutics’ Steve Holtzman said, “Our new headquarters in The Fenway will enable us to bring our capabilities under one roof, and sustain the cross-disciplinary exchange needed to conduct breakthrough science, while supporting our growth.”
For comments, questions or concerns, please contact Dennis Kaiser
- ◦Lease
